Zobrazeno 1 - 10
of 27
pro vyhledávání: '"William A. Wilmer"'
Publikováno v:
In Kidney International September 2001 60(3):858-871
Autor:
Rose L. Shim, Raul A. Hernandez, Lee A. Hebert, Christopher Valentine, Tibor Nadasdy, Brad H. Rovin, Anjali A. Satoskar, Leena Hiremath, Chadwick E. Barnes, William A. Wilmer
Publikováno v:
Nephron Clinical Practice. 119:c145-c153
Background: Relapse or worsening of nephrotic syndrome (NS) in idiopathic membranous nephropathy (IMN) is generally assumed to be due to recurrent disease. Here we document that often that may not be the case. Subjects and Methods: This is a prospect
Autor:
Cynthia Dixon, Ling Lu, Huijuan Song, Brad H. Rovin, William A. Wilmer, Xilin Chen, Xiaolan Zhang
Publikováno v:
Kidney International. 65(3):798-810
Stress protein activation by the cyclopentenone prostaglandin 15-deoxy-Δ 12,14 -prostaglandin J 2 in human mesangial cells. Background The cyclopentenone prostaglandin 15-deoxy-Δ 12,14 -prostaglandin J 2 (15dPGJ 2 ) affects mesangial proliferation,
Publikováno v:
American Journal of Kidney Diseases. 37:797-806
Calciphylaxis is a severe complication of chronic renal failure, confined almost exclusively to patients on dialysis therapy. Histological characteristics of calciphylaxis include small-vessel calcifications of skin, subcutaneous tissue, and visceral
Publikováno v:
Cytokine. 11:118-126
Mitogen-activated protein (MAP) kinases have been suggested as potential mediators for interleukin 1beta (IL-1beta)-induced gene activation. This study investigated the role of the MAP kinases p38 and ERK2 in IL-1beta-mediated expression of the chemo
Publikováno v:
Journal of Biological Chemistry. 272:10877-10881
Interleukin-1β (IL-1β) significantly influences renal cellular function through the induction of several gene products. The molecular mechanisms involved in gene regulation by IL-1β are poorly understood; however, the appearance of novel tyrosine
Autor:
Renee F. McElligott, Sherri L. Powell, Donald F. Middendorf, Steven E. Donelan, Sandra M. Frabott, Todd E. Pesavento, William H. Bay, William A. Wilmer
Publikováno v:
Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis. 21:411-413
Autor:
Christopher J. Hebert, Sunil V. Rao, William A. Wilmer, Brad H. Rovin, Lee A. Hebert, Karen Kumor
Publikováno v:
Journal of the American Society of Nephrology : JASN. 14(12)
It is widely accepted that proteinuria reduction is an appropriate therapeutic goal in chronic proteinuric kidney disease. Based on large randomized controlled clinical trials (RCT), ACE inhibitor (ACEI) and angiotensin receptor blocker (ARB) therapy
Publikováno v:
American journal of kidney diseases : the official journal of the National Kidney Foundation. 41(6)
Background: Peritoneal dialysis (PD) peritonitis is usually caused by infection and less commonly by a sterile inflammatory reaction. Methods: The authors report the case of a kidney-pancreas transplant recipient who was receiving PD after kidney tra
Publikováno v:
Antioxidantsredox signaling. 4(6)
Transforming growth factor-beta1 (TGF-beta1) mediates the development of glomerulosclerosis by stimulating mesangial cell production of extracellular matrix (ECM) proteins. TGF-beta1 and several ECM genes are regulated by promoter O-tetradecanoylphor